- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Software supports imaging research
New imaging and measurement technology may help vascular surgeons predict the risk of potentially fatal ruptures in patients with abdominal aortic aneurysms. Medical Metrx Solutions, a leading provider of 3D medical imaging and metrics, is providing
New imaging and measurement technology may help vascular surgeons predict the risk of potentially fatal ruptures in patients with abdominal aortic aneurysms. Medical Metrx Solutions, a leading provider of 3D medical imaging and metrics, is providing technology for use in a multicenter clinical study to evaluate the rupture risk of AAAs. Reliable assessment of rupture risk in patients is important to reduce aneurysm-related mortality while avoiding unnecessary surgery. The company's optimized 3D reconstruction and finite element analysis technology generate patient-specific stress maps that illustrate aortic aneurysm wall stress. Metrx is also providing core lab services for the clinical trial through its data communication infrastructure, allowing participants to enter study data online.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
